Introduction
Tumor necrosis factor (TNF)-a is a potent cytokine produced by many cell types in response to inflammation, infection, and environmental stimuli, which leads to a variety of cellular responses such as cell proliferation, differentiation, and apoptosis (Tracey and Cerami, 1993; Baud and Karin, 2001) . TNF-a is a representative of trimeric cytokine such as Fas ligand, lymphotoxin-a, and TNF-related apoptosis-inducing ligand (TRAIL) (Locksley et al., 2001) , and exerts its effects through two distinct receptors, TNF-R1 and TNF-R2 (Vandenabeele et al., 1995) . Although both receptors act to potentiate inflammation and share the common ability to activate the pleiotropic transcription factor NF-kB, TNF-R1 alone can trigger apoptosis whereas TNF-R2 mainly promotes cell survival (Grell et al., 1999) .
TNF-a signaling elicits two opposite effects: apoptosis and NF-kB activation (Hsu et al., 1995 (Hsu et al., , 1996a Wang et al., 1998) . During initiation of apoptosis, TNF-R1 signaling, like CD95, activates the proteolytic caspase cascade by recruiting caspase-8 via TRADD and FADD to the activated receptor (Boldin et al., 1995; Chinnaiyan et al., 1995) . In contrast, with respect to stress signaling and immune responses, TRADD also binds to RIP and TRAFs, and activates JNK or NF-kB (Bradley and Pober, 2001) . Among them, TRAF-2, -5, and -6 have been shown to mediate NF-kB activation (Rothe et al., 1995; Cao et al., 1996; Ishida et al., 1996a, b; Liu et al., 1996) . Subsequent activation of IKKs leads to the phosphorylation of IkBs for degradation and the activation of NF-kB (Mercurio et al., 1997; Woronicz et al., 1997) .
FLICE-associated huge protein (FLASH) was originally identified as a component of death-inducing signaling complex (DISC) involved in Fas-and TNFa-mediated apoptosis and contained a death effector domain-recruiting domain (DRD), which interacted with death effector domain (DED) of caspase-8 or FADD (Imai et al., 1999) . However, its effect on apoptosis was not clearly shown. Recently, we reported that FLASH coordinates NF-kB activity via TRAF2-dependent pathway through NF-kB-activating domain (NAD) (Choi et al., 2001) . Caspase-8 is mainly known for its function to mediate cell death triggered by various death receptors belonging to the TNF-R family (Nagata, 1999; Sprick et al., 2000) . However, there is emerging evidence that caspase-8 and FADD may be required for cell proliferation and development of the heart, bone, and thymus (Newton et al., 1998; Inoara et al., 2000; Ito et al., 2001) . Moreover, recent reports suggested that caspase-8 might also have a role in NFkB activation as assessed by overexpression experiments (Chaudhary et al., 2000; Hu et al., 2000) .
In this study, by employing antisense (AS) approaches using siRNA and AS cDNA and by using caspase-8-deficient cells, we showed the contribution of endogenous caspase-8 and FLASH to TNF-a-induced activation of NF-kB. In vitro and in vivo binding assays using a DED mutant of caspase-8 revealed that DRD of FLASH interacted with DED of capase-8 to mediate NF-kB activation. Further, a FLASH-deletion mutant containing only DRD inhibited TNF-a-and caspase-8-mediated activation of NF-kB. These results indicate that endogenous caspase-8 plays a crucial role in NF-kB activation via FLASH.
Results

Reduction of endogenous caspase-8 attenuates TNF-a-induced activation of NF-kB
To investigate the contribution of endogenous caspase-8 to TNF-a-induced activation of NF-kB, we directly targeted the expression of caspase-8 in HeLa cells by using pEGFP-AS-caspase-8 plasmid expressing caspase-8 cDNA in AS orientation (Figure 1a ). TNF-a-induced activation of NF-kB was decreased by threefold in such HeLa cells showing reduced expression of caspase-8 as measured with the NF-kB luciferase reporter assays ( Figure 1a ). Similar effect was observed in HEK293 cells; transient transfection with pEGFP-AS-caspase-8 suppressed TNF-a-induced activation of NF-kB to the control level. We also generated stable NIH3T3 cells expressing reduced amounts of caspase-8 (NIH3T3/psicasp8) using siRNA ( Figure 1b ). NIH3T3/psi-casp8 cells were resistant to death triggered by cotreatment with TNF-a and cycloheximide (Supplementary Figure 1) .
TNF-a-induced activation of NF-kB was clearly reduced in NIH3T3/psi-casp8 cells compared to that of NIH3T3/pSuper control cells (Figure 1b ) and partially restored after reconstitution with processing-defective Figure 1 Suppression of TNF-a-induced activation of NF-kB by downregulation of caspase-8. (a) HeLa and HEK293 cells were transiently transfected with NF-kB luciferase reporter plasmid (pNF-kB-luc), pCMV-b-galactosidase (pCMV-b-gal), and either pEGFP (Vector) or pEGFP-AS-caspase-8 plasmid for 30 h. The cells were treated with TNF-a (20 ng/ml) for additional 18 h. Western blot analysis of HeLa cell extracts was performed using anti-caspase-8, anti-caspase-3, and anti-tubulin antibodies. Luciferase activity was measured and normalized by that of internal control, b-galactosidase. Bars represent means7s.d. from three independent experiments. (b) NIH3T3 cells stably transfected with pSuper (NIH3T3/pSuper) or psi-caspase-8 (NIH3T3/psi-casp8) were selected for 2 weeks with G418 (1 mg/ml) and examined for the expression of caspase-8 with Western blotting. TNF-a-induced activation of NF-kB was then determined in those NIH3T3 cells after transfection with pNF-kB-luc. Further, TNF-a-induced increase of c-FLIP expression, which is mediated by the NF-kB activity (Kreuz et al., 2001; Micheau et al., 2001) , was not observed in HeLa cells transfected with pEGFP-AS-caspase-8 (Figure 1e ). These results indicate that endogenous caspase-8 contributes to TNF-a-induced activation of NF-kB.
Reconstitution of caspase-8-deficient cells with inactive caspase-8 restores TNF-a-triggered activation of NF-kB
We found that C33A cell line is deficient in caspase-8 as examined with Western blot analysis (Figure 2a) . Treatment of C33A cells with TNF-a failed to elicit NF-kB activation. On the contrary, subsequent reconstitution with P/D-caspase-8 sensitized C33A cells to TNF-a-triggered activation of NF-kB (Figure 2a) , as similarly shown in NIH3T3/psi-casp8 cells (Supplementary Figure 2 ), indicating that the enzymatic activity of caspase-8 is not likely to be required for TNF-atriggered activation of NF-kB. Transient expression of caspase-8 in the presence of acetyl-z-Ile-Glu-Val-Aspphenyl-methyl-ketone (z-IETD-fmk), caspase-8 inhibitor, also restored TNF-a-induced activation of NF-kB (Figure 2b ), confirming that caspase-8 mediates TNF-a signal leading to NF-kB activation independent of its enzymatic activity.
FLASH is a downstream mediator for caspase-8-induced activation of NF-kB
We have previously shown that FLASH coordinates TNF-a-induced activation of NF-kB through TRAF2 (Choi et al., 2001) . In order to address whether FLASH is required for caspase-8-mediated activation of NF-kB, the expression of FLASH was reduced by AS oligonucleotides (AS-2). Treating HEK293 cells with FLASH AS-2, but not with scrambled oligonucleotides, abolished caspase-8-triggered activation of NF-kB ( Figure 3a ) and the diminished expression of FLASH was confirmed by RT-PCR and Western blot analyses (Figure 3b ), indicating that FLASH mediates caspase-8-triggered activation of NF-kB.
In the previous report (Choi et al., 2001) , we defined NAD in the N-terminal region of FLASH for the protein-protein interaction with TRAF2. We also showed that the truncated mutant of FLASH (DD-FLASH (1191 -1962 ), which contains only the caspase-8-binding DRD in the C-terminal region, was able to bind to caspase-8 but failed to induce NF-kB activation as compared with FLASH. We hypothesized that DD-FLASH mutant might function as a dominantnegative (DN) of FLASH by interacting with caspase-8 without NF-kB activation due to lack of NAD, and thus -FLASH (1191 -FLASH ( -1962 mutant completely blocked NF-kB activation induced by the expression of P/D caspase-8 mutant (Figure 4c ). These results suggest that FLASH is a downstream mediator of caspase-8 in the signaling pathway leading to NF-kB activation and DD-FLASH mutant may function as a DN of FLASH.
Caspase-8 (D73A) mutant fails to bind to FLASH in vitro and in vivo
Site-directed mutagenesis of caspase-8 and NF-kB reporter assays showed that the caspase-8 (D73A) mutant not only failed to induce NF-kB activation (Chaudhary et al., 2000) , but inhibited the activation of NF-kB induced by P/D-caspase-8 mutant (Figure 4c ). These observations led us to examine a functional interaction between FLASH and caspase-8 (D73A) mutant. In vitro GST pull-down assay revealed that in contrast to caspase-8, caspase-8 (D73A) mutant did not interact with DRD of FLASH and FADD in vitro Figure 5 ). These results suggest that the impairment of caspase-8 (D73A) mutant to induce NF-kB activation may result from its inability to interact with FLASH and support our proposal that the protein-protein interaction between caspase-8 and FLASH may modulate caspase-8-mediated activation of NF-kB.
Interestingly, caspase-8 (D73A) mutant still possessed its ability to interact with caspase-8 (Figure 6c ). Thus, we examined the effects of caspase-8 (D73A) mutant on TNF-a signaling pathway: expression of caspase-8 (D73A) mutant abolished TNF-a-induced activation of NF-kB (Figure 7 ) independent of caspase-8 activity as evidenced by the presence of IETD-fmk. These results together with the data presented in Figure 4c suggest that though caspase-8 (D73A) mutant fails to induce NF-kB activation, it may inhibit caspase-8-mediated activation of NF-kB probably by interacting with caspase-8.
TNF-a induces the formation of caspase-8-TRAF2-FLASH triple complex
Next, we examined the recruitment of endogenous caspase-8 into TNF-R signaling complex. In contrast to anti-Fas antibody, immunoprecipitation assays using anti-TNF-R antibody were unable to elucidate clearly the recruitment of endogenous caspase-8 into TNF-R complex (data not shown). Instead, we tried to detect the caspase-8-FLASH-TRAF2 triple complex, while the protein-protein interaction of FLASH with TRAF2 was previously shown (Choi et al., 2001) . Owing to the limitation of anti-FLASH antibody, we generated stable HEK293 cells expressing HA-tagged FLASH (HEK293/ HA-FLASH). Western blot analysis using anti-caspase-8 and anti-TRAF2 antibodies following immunoprecipitation with anti-HA antibody revealed that endogenous caspase-8 and TRAF2 were detected in the immunocomplex containing HA-FLASH, indicating that caspase-8 and TRAF2 form complexes with HA-FLASH, which appears to be increased by the treatment with TNF-a (Figure 8 ). These results together provide more evidence for the proposed role of proximal caspase-8 in the TNF-a signaling pathway leading to NF-kB activation.
Discussion
Although the main paradigm for the function of caspase-8 is the initiation of caspase cascade during Fas, TNF-a, and TRAIL-induced apoptosis, increasing evidence suggests that caspase-8 may also be required for nonapoptotic function, such as cell survival and proliferation (Ito et al., 2001; Newton et al., 2001; Chun et al., 2002) . Here, we showed that endogenous caspase-8 and FLASH play a role in transducing TNF-a signal to NF-kB activation in the cells we have examined, providing more evidence to the earlier reports exhibiting overexpression effects of caspase-8 on NF-kB activation (Chaudhary et al., 2000; Hu et al., 2000; Shikama et al., 2003) . Also, the previous results showing TNF-ainduced degradation of IkBa in caspase-8 knockout (À/À) embryo fibroblast cells revealed that TNF-ainduced activation of NF-kB seemed to be retarded (Varfolomeev et al., 1998) , further supporting our results that endogenous caspase-8 is required for TNFa-induced activation of NF-kB in NIH3T3 and HeLa cells.
A typical pathway to NF-kB activation triggered by death receptor, especially TNF-R, goes through TRADD-RIP-TRAF2-IKKs cascade (Hsu et al., 1996b; Woronicz et al., 1997; Zandi et al., 1997) . We propose that FLASH also can transduce signals for TNF-a-triggered and caspase-8-mediated activation of NF-kB by interacting with caspase-8 and TRAF2 (Figure 9 ). Then, questions arise whether caspase-8 and FLASH are the components of the TNF-R signaling complex, which have never been clearly shown before in spite of numerous evidences suggesting that caspase-8 and FADD are essential components of TNF-R-containing DISC. Most of the proposals based on the genetic evidence using caspase-8-deficient cells or their DN mutants without showing endogenous TNF-R complex (Chaudhary et al., 2000; Hu et al., 2000) . Similarly, our genetic analysis using caspase-8-deficient cells implicates that at least caspase-8 is an essential component of TNF-a signaling pathway leading to NF-kB activation. Unlike Fas and TRAIL-R, difficulty to show such TNF-R complex by immunoprecipitation assay may result from an unidentified additional factor that is required for the formation of TNF-R complex in vivo but labile to the milieu of immunoprecipitation assay. Alternatively, caspase-8 may form a part of soluble signaling complex, distinct from the receptor-associated complex but still regulated by TNF-a. Recently, Micheau and Tschopp (2003) reported the existence of soluble cytosolic complex containing both caspase-8 and FADD induced by the treatment of TNF-a.
We have extensively examined in vivo association of caspase-8 with TNF-R, TRAF2, and FLASH with the immunoprecipitation assays using various combinations of antibodies. While the presence of caspase-8 in the TNF-R immunocomplex could not be clearly resolved, we consistently observed the formation of the immunocomplex containing caspase-8, TRAF2, and FLASH in HEK293/HA-FLASH cells after treatment with TNF-a. We believe that FLASH and unidentified additional factor(s) may be included in the immunocomplex to regulate apoptosis and/or NF-kB activation, which remains to be further elucidated. Our present experimental model is that caspase-8 may form a cytosolic complex with TRAF2 via FLASH, facilitating TNF-amediated activation of NF-kB in the cells we have examined.
It is notable that forced expression of DD-FLASH mutant inhibited TNF-a-and caspase-8-induced activation of NF-kB. It is likely that DD-FLASH mutant may act as a DN inhibiting NF-kB activation: Like FLASH, DD-FLASH mutant binds to caspase-8 through DRD of its Cterminus. Unlike FLASH, DD-FLASH mutant fails to elicit NF-kB activation (Choi et al., 2001 ) and instead inhibits both TNF-a and caspase-8-mediated activation of NF-kB. We speculate that the expression of DD-FLASH mutant may sequester caspase-8 from cytosol or DISC, thus inhibiting caspase-8-mediated activation of NF-kB. Our proposal is reinforced by the observations that expression of DD-FLASH mutant inhibited the activation of NF-kB triggered by TNF-a, a death receptor signal, but not by PMA, a nonreceptor signal (Figure 4 ). Also, putative nuclear localization signal found in FLASH (at residues 1813-1830) may be exposed to be functional in the DD-FLASH mutant for the sequestration of its binding partner. Thus, DD-FLASH mutant may be a promising tool to examine the upstream signals of FLASH, including membrane receptors, and to analyse the functional cooperation of caspase-8 and FLASH in various signals leading to the activation of NF-kB and cell death.
While the protease activity of caspase-8 also is likely required for the nonapoptotic function such as cell proliferation and NF-kB activation of some cell types (Choi et al., 2002; Chun et al., 2002) , our results suggest that DED of caspase-8 is responsible for NF-kB activation through the protein-protein interaction in our experimental systems. Based on the observations that caspase-8 (D73A) mutant did not bind to DRD of FLASH but suppressed TNF-a-induced activation of NF-kB, and formed intracellular complex with caspase-8, we speculate that caspase-8 (D73A) mutant may prevent caspase-8 from binding to another molecules, such as FLASH, involved in NF-kB activation. FLASH seems to be a downstream mediator of various receptors and is most likely to have a dual function in the regulation of apoptosis and NF-kB activation. Like caspase-8, FLASH is an indispensable component of apoptosis triggered by TNF-a and Fas, but not by nonreceptor signals (unpublished data), and interacts with TRAF2 for NF-kB activation. Remaining puzzle is how caspase-8 and FLASH execute these two contradictory functions, NF-kB activation and apoptosis. The complex containing caspase-8 and FLASH may need regulatory factor(s), including TRAFs, TRADD, or RIP for NF-kB activation and c-FLIP and IAP for apoptosis (Beg and Baltimore, 1996; LaCasse et al., 1998; Kreuz et al., 2001; Micheau et al., 2001; Guiet et al., 2002; Shikama et al., 2003) , which remains to be further clarified. Figure 9 Schematic diagram of TNF-a-induced activation of NFkB via caspase-8 and FLASH. When cells were exposed to TNF-a alone, caspase-8 interacts with the DRD of FLASH and transduces the signal to TRAF2 for NF-kB activation. However, during apoptosis, caspase-8 is processed into active form for the execution of apoptosis
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Materials and methods
Reagents and expression plasmids
Caspase-8 inhibitor, z-IETD-fmk, was purchased from Bachem (Torrance, CA, USA). Anti-IkBa (SC-37), anti-p65 (SC-372), anti-FLIP S/L (SC-3847), anti-TRAF2 (SC-7346, 7868), anticaspase-3 (SC-7148), and anti-TNF-R (p55) (SC-7895) antibodies were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Anti-FLASH antibody (AB3605) was from CHEMICON (Temecula, CA, USA). Anti-FADD antibody (36620) was from Upstate Biotech Inc. (Waltham, MA, USA) and anti-caspase-8 antibody was described previously (Kim et al., 2000) . Anti-HA antibody was from Pharmingen (San Diego, CA, USA) and Boehringer Mannheim (Mannheim, Germany), respectively. Anti-Flag (M2) monoclonal antibody and all other molecular biology grade materials were from Sigma Chemical Co. (St Louis, MO, USA). Human TNF-a and PMA were purchased from Calbiochem (La Jolla, CA, USA). Caspase-8 (D73A)-Flag expression plasmid was kind gift from Dr P Chaudhary (University of Texas). Caspase-8 was cloned into BamHI/KpnI sites of pcDNA3 (Invitrogen, The Netherlands), and P/D-caspase-8 replacing Asp at residues 374 and 384 with Glu was generated by site-directed mutagenesis using megaprimer PCR and subcloned into pcDNA3. pHA-DD-FLASH was described previously (Choi et al., 2001) . DRD-FLASH (1584 -1785 and FADD were fused to GST of pGEX4T-1 (Amersham Pharmacia Biotech., England) (GST-DRD, GST-FADD). The pNF-kBluciferase plasmid (pNF-kB-luc) includes the four copies of IL-2 consensus sequence for NF-kB binding fused to the sequence encoding firefly luciferase gene (Choi et al., 2001 ).
Caspase-8 siRNA analysis
The RNAi procedure was described previously (Brummelkamp et al., 2002) . In brief, double-stranded oligonucleotides were designed to contain a sequence derived from the 5 0 -end of human caspase-8 ORF (nucleotides 694-712) in forward and reverse orientation separated by a 9-base-pair spacer region (ttcaagaga) to allow formation of the hairpin structure in the expressed oligo-RNA: sense strand, 5 0 -gatccccCCTCGGG GATACTGTCTGAttcaagaga TCAGACAGTATCCCCGA GGtttttggaaa; AS strand, 5 0 -agcttttccaaaaa GGAGCCCC TATGACAGACTtctcttgaaAGTCTGTCATAGGGGCTCCggg. The resulting double-stranded oligonucleotides were cloned into the BglII and HindIII sites of the pSuper-neo (OligoEngine, Seattle, WA, USA) for expression under the control of the H1 RNA promoter (psi-caspase-8). NIH3T3 cells were transfected with pSuper or psi-caspase-8 for 30 h and neomycin-resistant clones were selected for 2 weeks after incubation with G418 (1 mg/ml).
Cell culture and DNA transfection
HeLa and C33A, human cervical epithelial cells, HEK293, human embryonic kidney cells, and NIH3T3, mouse fibroblast cells were maintained in Dubelcco's modified Eagle's medium (Life Technologies) supplemented with 10% fetal bovine serum (HiCLONE, Australia). Stable cell lines were generated as described previously . For transfection, cells were subcultured to a density of 2 Â 10 5 cells/well in a 12-well dish and allowed to stabilize for 24 h. Cells were then transfected with plasmids using LipofectAMINE plus reagent according to the manufacturer's instruction (Invitrogen). The total amount of transfected DNAs was kept constant within individual experiments by adding appropriate amounts of pcDNA.
AS oligonucleotide treatment
FLASH AS oligonucleotides (AS-2) (5 0 -ATTCAGCAACT TACTTGC-3 0 ) corresponds to a location around the stop codon, 5942-5959 bp, downstream of the translation initiation site. Comparison of this oligonucleotide sequence with the database detected the only homology to the FLASH sequence. The following scrambled sequence was used as a control: 5 0 -GCTACTAGTTAGCAGCTAC-3 0 . HEK293 cells (3 Â 10 6 per wells) were continuously treated with 5 mM FLASH AS or the scrambled oligonucleotide for 36 h in culture medium containing LipofectAMINE reagent.
RNA isolation and RT-PCR
Total RNA was isolated from HEK293 cells using TRIzol reagent (Gibco BRL). RT-PCR was performed for quantification of FLASH mRNA and b-actin mRNA as a control. Two sets of oligonucleotides were designed: 5 0 -GAAGGTAAT CATCCTGCATTAGCTGT-3 0 (sense) and 5 0 -GAGCTTCAT TAGCTGCTGGAATCTT-3 0 (antisense) (predicted product length: 714 bp) for FLASH primers. The nucleotide sequences of the b-actin primes were 5 0 -CAACCGCGAGAAGATGA CCC-3 0 (sense) and 5 0 -GAAGGAAGGCTGGAAGAGTG-3 0 (antisense) (predicted product length: 457 bp). The PCR products were subjected to and confirmed by DNA sequencing analysis.
Luciferase and b-galactosidase assays
Luciferase activities in the cell extracts were determined using a luciferase assay system (Promega, WI, USA) and luminometer (LB 9501, Berthord, Australia). To measure b-galactosidase activity, the cell extracts were mixed with equal amounts of b-galactosidase assay buffer (2 Â ) containing 200 mM sodium phosphate (pH 7.3), 2 mM MgCl 2 , 100 mM b-mercaptoethanol, and 1.33 mg/ml O-nitrophenyl-b-galactopyranoside, and incubated for 30 min at 371C. The absorbance at 420 nm was then measured using an ELISA reader (Molecular Device, Sunnyvale, CA, USA).
Preparation of cytosolic and nuclear extracts
The cell pellet (3 Â 10 6 cells) was suspended in 200 ml of cytosolic extract (CE) buffer (10 mM HEPES (pH 7.6), 60 mM KCl, 1 mM EDTA, 0.075% Nonidet P-40, 1 mM DTT including the protease inhibitor mixture), incubated on ice for 3 min, and centrifuged at 1500 g for 4 min at 41C. The supernatant (CE) was transferred and the pellet (nuclei) was washed with 1 ml CE buffer without Nonidet P-40. The nuclei were pelleted as above, followed by suspending in 70 ml of NE buffer (20 mM Tris-HCl (pH 8.0), 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 25% (v/v) glycerol, and protease inhibitors), and incubated on ice for 10 min with frequent mixing. Finally, the suspension was centrifuged at 14 000 g for 10 min at 41C.
Western blot analysis
Western blotting were performed as described previously . Briefly, cells were resuspended in SDSsample buffer. Protein concentrations were determined using a protein assay kit (Dc protein assay, Bio-Rad, Richmond, CA, USA). The samples were subjected to SDS-PAGE, transferred to PVDF membranes, probed with primary and secondary antibodies, and visualized using enhanced chemiluminescence system according to the manufacturer's instructions (ECLt, Amersham Pharmacia Biotech).
In vitro binding assay Assay was performed as described previously (Choi et al., 2001) . Briefly, the expression of GST fusion proteins in BL21 (DE3) harboring pGEX-4T-1, pGEX-DRD, or pGEX-FADD was induced with 100 mM isopropyl-b-D-thiogalactoside. Harvested cells were lysed by sonication in 50 mM Tris-HCl buffer (pH 7.4) containing 1 mM DTT, 0.5 mM EDTA, and 10% (v/v) glycerol. The supernatant were incubated with glutathionesepharose 4B (Amersham-Pharmacia Biotech). Wild-type and D73A mutant of caspase-8 were labeled with [
35 S]methionine using the TNT system (Promega) and then added to GST fusion proteins (20 mg each) coupled to glutathione-sepharose 4B in a final volume of 500 ml of binding buffer containing 50 mM Tris-HCl (pH 7.4), 1 mM DTT, 0.5 mM EDTA, 0.01% Triton X-100, 0.5 mg/ml bovine serum albumin, and 10% (v/v) glycerol. After being incubated for 2 h at 41C with gentle mixing, the beads were washed three times with the binding buffer, separated by 12% SDS-PAGE, and detected by autoradiography.
Immunoprecipitation analysis
Cells were lysed with the lysis buffer containing 50 mM Tris-HCl (pH 7.4), 1% Nonidet P-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM PMSF, 1 mg/ml each of leupeptin, aprotinin, pepstatin, 1 mM Na 3 VO 4 , and 1 mM NaF. Protein complexes were immunoprecipitated from the lysates after incubation with anti-HA, anti-Flag, anti-TNF-R, or anti-TRAF2 antibody, and protein-A-coupledsepharose CL-4B for 2 h at 41C, and detected by Western blot analysis.
